Training cover

DIRECT HF Educational Program: Sudden Cardiac Death Prevention in Contemporary Heart Failure Care


Gratuit


Heart Failure Learning Hub

4.4

· 64 Avis

Voir le catalogue
À propos Intervenants Public cible

À propos

01h00

Anglais

We are excited to announce that the first session of the DIRECT HF Educational Program, “Sudden Cardiac Death Prevention in Contemporary HF Care,” is now available on demand. Led by esteemed program chairs Cecilia Linde and Koichiro Kinugawa, this session provided critical insights into improving heart failure management and preventing sudden cardiac death.

This impactful webinar brought together leading experts to discuss the integration of guideline-directed cardiac rhythm management therapies into comprehensive HF care. If you missed the live session, this is your chance to gain valuable knowledge and practical strategies to enhance patient outcomes.


What You’ll Learn:

Introduction to the DIRECT HF educational program (3 min)

Cecilia Linde


Cardiac rhythm management devices: cornerstones of comprehensive, patient-centered HF care (10 min)

Shelley Zieroth, Wilfried Mullens

· Global epidemiology and burden of HF

· Treatment objectives and personalized care

· Comprehensive HF care: overview of management options

· Integration of implantable device therapy in HF care

· Timing of drug and device therapy

· Gaps in HF guideline implementation and barriers to optimal HF care


Prevention of sudden cardiac death: relevance in contemporary HF care (20 min)

Christophe Leclercq, Gianluigi Savarese, Biykem Bozkurt

· Risk of SCD in HFrEF in the current era of pharmacological therapy

· Efficacy and safety of ICD therapy in HFrEF

· Eligibility criteria for ICD therapy in clinical practice guidelines

· What determines the mortality benefit of ICD therapy?

· Personalized SCD risk stratification

· Timing of referral for ICD implantation: the need for an individualized approach

· Case discussion


ICD therapy in HF: the patient’s perspective (10 min)

Loreena Hill, Alexandre Mebazaa, Naoki Sato and patient representatives

· Patients’ needs and perceptions with respect to implantable cardiac devices

· Shared decision making in practice: the patient as a partner


Panel discussion (15 min)

Antoni Bayes-Genis, Koichiro Kinugawa, Christophe Leclercq, Cecilia Linde,

Naoki Sato, Gianluigi Savarese


Conclusion (2 min)

Koichiro Kinugawa



What’s Next?

Save the date for our next session on February 20th, 2025, where we’ll discuss ICDs and CRT therapy in optimizing care for patients with HFrEF.


References:

Levy WC. J Am Coll Cardiol. 2017;69:1679-82

Hammersley DJ et al. J Am Coll Cardiol. 2024; Aug 29 [Online ahead of print]

Shadman R et al. Heart Rhythm. 2015;12:2069-77; Levy WC et al. JACC Clin Electrophysiol. 2017;3:291-8

Younis A et al. Eur Heart J. 2021;42:1676-84

Schrage B et al. Eur J Heart Fail. 2022;24:1212-22

Chrispin J et al. J Am Coll Cardiol. 2023;82:735-747

Yan T et al. J Am Heart Assoc. 2023;12:e027852; 2. Bragazzi NL et al. Eur J Prev Cardiol. 2021;28:1682-90

Piña IL. UpToDate® 2024;

Bragazzi NL et al. Eur J Prev Cardiol. 2021;28:1682-90;

Rubio R et al. BMJ Open. 2021;11:e053216;

Major K et al. Cardiol J. 2024;31:156-67; 5. Johansson I et al. Circulation. 2021;143:2129-42; Savarese G et al. Cardiovasc Res. 2023;118:3272-87; 7. Ketabi M et al. Curr Cardiol Rep. 2024; Sep 4 [Online ahead of print]

Rumsfeld JS et al. Circulation. 2013;127:2233-49.

ESC clinical practice guidelines on the management of chronic and acute heart failure:

what patients need to know. European Society of Cardiology, 2022

Tromp J et al. JACC Heart Fail. 2022;10:73-84

Bozkurt B et al. Nat Rev Cardiol. 2024;21:545-555

Januzzi JL et al. JAMA. 2019;322:1085-1095;

Felker GM et al. Circulation. 2021;144:180-182 Fan, Gang et al. European Journal of Internal Medicine, Volume 114, 49 - 57

Veltmann C et al. Eur Heart J. 2024;45:2771-2781

Leyva F et al. Circulation. 2023;147:759-67

Polovina M et al. Eur J Heart Fail. 2023;25:2144-63

Desai AS et al. Eur Heart J. 2015;36:1990-7; Curtain JP et al. Eur Heart J. 2021;42:3727-38

Rohde LE et al. JACC Heart Fail. 2020;8:844-55

Køber L et al. N Engl J Med. 2016;375:1221-30

Elming MB et al. Circulation. 2017;136:1772-80

Shun-Shin MJ et al. Eur Heart J. 2017;38:1738-46

Ahmed A et al. JACC Clin Electrophysiol. 2024;10:916-26

Dhande M et al. JACC Clin Electrophysiol. 2022;8:1024-30

Heidenreich PA et al. J Am Coll Cardiol. 2022;79:e263-e421; McDonagh TA et al. Eur Heart J. 2021;42:3599-726;

Tsutsui H et al. Circ J. 2019;83:2084-184; Ezekowitz JA et al. Can J Cardiol. 2017;33:1342-433

McMurray JJ et al. N Engl J Med. 2014;371:993-1004; McMurray JJV et al. N Engl J Med. 2019;381:1995-2008;

Packer M et al. N Engl J Med. 2020;383:1413-24

Mullens W et al. Eur J Heart Fail. 2020;22:2349-69 & Europace. 2021;23:1324-42 (sources: EHRA White book & Medtech Europe)

Heidenreich PA et al. J Am Coll Cardiol. 2022;79:e263-e421

Mullens W et al. Eur J Heart Fail. 2020;22:2349-69 & Europace. 2021;23:1324-42

Mullens W et al. Eur J Heart Fail. 2024;26:483-501

Gallacher K et al. Ann Fam Med. 2011;9:235-43

Jaarsma T et al. Eur J Heart Fail. 2021;21:157-74

Allen LA et al. Circulation. 2012;125:1928-52;

Perpetua EM et al. JACC Adv. 2024;3:100981;

Elwyn G et al. J Gen Intern Med. 2012;27:1361-7

Pedersen SS et al. Europace. 2017;19:983-90; Hill LM et al. BMJ Support Palliat Care. 2022;12:e219-e25;

Hill L et al. Eur J Heart Fail. 2020;22:2327-39; Colorado Program for Patient Centered Decisions.

A decision aid for Implantable Cardioverter-Defibrillators (ICD); available at: https://www.patientdecisionaid.org/icd

Papageorgiou V et al. ESC Heart Fail. 2021;8:3760-8

Speakers icon

Intervenants

Speaker Avatar
Prof. Wilfried Mullens Hospital Oost-Limburg (ZOL), Genk (Belgium)
Speaker Avatar
Dr Gianluigi Savarese Karolinska University Hospital, Stockholm, Sweden
Speaker Avatar
Dr Antoni Bayes-Genis Head of the Heart Institute at Hospital Universitari Germans Trias i Pujol in Badalona (Barcelona, Spain), director of the ICREC (Heart Failure and Cardiac Regeneration) Research Program
Speaker Avatar
Prof. Biykem Bozkurt Baylor College of Medicine, Houston (United States of America)
Speaker Avatar
Prof. Cecilia Marianne Linde Cardiologist and a Professor in Cardiology at the Heart and Vascular Theme at the Karolinska University Hospital and the Karolinska Institutet in Stockholm, Sweden
Speaker Avatar
Dr. Shelley Zieroth Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St. Boniface Hospital in Winnipeg, Canada.
Target audience icon

Public cible

L’évènement est à destination des praticiens ou spécialités ci-dessous :

Cardiologie et maladies vasculaires - Cardiologie interventionnelle

Cardiologie et maladies vasculaires

Contact icon

Contactez l’équipe Invivox

Discussion instantanée

- Chat disponible en bas à gauche